Download

Download Full Text (413 KB)

Contents

  • Specialized Care Improves Lives of patients With Head and Neck Lymphedema: A unique program is producing dramatic results for patients with head and neck lymphedema, a side effect of cancer treatment that can interfere with patient's ability to speak, swallow, or breath
  • Targeted Cancer Therapies May Help Overcome Resistance to Radiation Therapy: Some cancer cells are resilient enough to withstand and recover from the damage to their DNA caused by radiation therapy. But recent studies have shown that adding molecularly targeted agents to radiation therapy can prevent the repair of this radiation-induced damage and therapy improve the treatment response of patients with certain cancers
  • INBRIEF: New Test Helps Identify Glioblatoma Patients Who Could Benefit from Bevacizumab
  • HOUSE CALL: Depression in Cancer Patients: Managing depression improves quality of life and possibly cancer treatment outcomes

Publication Date

8-1-2013

Publisher

The University of Texas MD Anderson Cancer Center

City

Houston, Texas

Keywords

Lewin, Jan S.; Little, Leila; Smith, Brad; Welsh, James; Byers, Lauren; Sulman, Erik; Hung, Mien-chie; Valentine, Alan D.; Lymphedema; Molecular Targeted Therapy; Radiotherapy; Erlotinib Hydrochloride; Immunotherapy; Glioblastoma; Bevacizumab; Depression; Patients; Neoplasms.

Disciplines

History of Science, Technology, and Medicine | Oncology

Conditions Governing Access

Open

OncoLog, Volume 58, Number 08, August 2013

Share

COinS